Controlled trial of cephaloridine, lincomycin, and nafcillin in severe gram-positive coccal infections.
D000328:Adult; D002509:Cephaloridine / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D006801:Humans; D007239:Infections / Q000188:drug therapy*; D008034:Lincomycin / Q000008:administration & dosage*; D009254:Nafcillin / Q000008:administration & dosage*; D011008:Pneumococcal Infections / Q000188:drug therapy; D013203:Staphylococcal Infections / Q000188:drug therapy; D013290:Streptococcal Infections / Q000188:drug therapy
D009254:Nafcillin; D008034:Lincomycin; D002509:Cephaloridine